GeneDx Holdings (WGS) Operating Margin (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Operating Margin data on file, last reported at 56.2% in Q1 2026.

• Operating Margin for Q1 2026 came in at 56.2%, down 5098.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 14.91% (down 1064.0% YoY), and the FY2025 annual result was 3.06%, up 454.0% from the prior year.
• Operating Margin retreated to 56.2% in Q1 2026 per WGS's latest filing, from 11.77% in the prior quarter.
• Over five years, Operating Margin peaked at 9.21% in Q4 2024 and troughed at 529.56% in Q4 2022.
• A 5-year average of 101.77% and a median of 44.66% in 2023 frame the typical range for Operating Margin.
• The sharpest annual moves came in 2022 and 2023: Operating Margin sank 35302 bps in 2022, then surged 48489 bps in 2023.
• A 5-year view of Operating Margin shows it stood at 529.56% in 2022, then soared by 92 bps to 44.66% in 2023, then surged by 121 bps to 9.21% in 2024, then plunged by 228 bps to 11.77% in 2025, then slumped by 378 bps to 56.2% in 2026.
• Business Quant data shows WGS's Operating Margin at 56.2% in Q1 2026, 11.77% in Q4 2025, and 2.78% in Q3 2025.